Members |
targetComponentId |
Myocardial ischaemia |
Coronary artery atheroma |
Myocardial ischaemia |
Ischemic heart disease (disorder) |
Myocardial ischaemia |
Myocardial ischemia (disorder) |
Myocardial ischaemia |
Coronary arteriosclerosis |
Myocarditis - virus unidentified |
Viral myocarditis |
Myocarditis caused by avian influenza |
Myocarditis caused by Influenza A virus (disorder) |
Myocarditis: [isolated - Fiedler's] or [giant cell] |
Isolated (Fiedler's) myocarditis |
Myoclonic seizure |
Myoclonic disorder |
Myoclonic seizure |
An epileptic seizure consisting of sudden, brief (less than 100 milliseconds) involuntary single or multiple contraction(s) of muscle(s) or muscle groups of variable topography (axial, proximal limb, distal), regardless of whether focal, generalised, or unknown onset, and whether aware or impaired awareness. Myoclonus is less regularly repetitive and less sustained than is clonus. |
Myoclonus disorder &/or observation |
Myoclonus |
Myoclonus: [other] or [paramyoclonus multiplex] |
Myoclonic disorder |
Myoclonus: [other] or [paramyoclonus multiplex] |
Paramyoclonus multiplex |
Myocutaneoosseous transplantation |
Reconstruction using local osteomyocutaneous flap (procedure) |
Myocutaneoosseous transplantation |
Reconstruction using distant osteomyocutaneous flap (procedure) |
Myocutaneous transplantation |
Local myocutaneous flap |
Myocutaneous transplantation |
Distant myocutaneous flap |
Myoma screw, single-use |
Myoma screw |
Myomectomy (& open) |
Open myomectomy |
Myomectomy (& open) |
Uterine myomectomy |
Myopathy co-occurrent and due to polymyositis |
Polymyositis |
Myotomy (& [NEC] or [Irwin]) |
Division of muscle |
Myotomy (& [NEC] or [Irwin]) |
Irwin myotomy |
Myotonic disorders (& [dystrophia myotonica]) |
A rare genetic multi-system disorder characterised by a wide range of muscle-related manifestations (muscle weakness, myotonia, early onset cataracts before age 50) and systemic manifestations (cerebral, endocrine, cardiac, gastrointestinal tract, uterus, skin and immunologic involvement) that vary depending on the age of onset. The very wide clinical spectrum ranges from lethal presentations in infancy to mild, late-onset disease. |
Myotonic disorders (& [dystrophia myotonica]) |
Myotonic disorder |
Myotonic disorders |
A rare genetic multi-system disorder characterised by a wide range of muscle-related manifestations (muscle weakness, myotonia, early onset cataracts before age 50) and systemic manifestations (cerebral, endocrine, cardiac, gastrointestinal tract, uterus, skin and immunologic involvement) that vary depending on the age of onset. The very wide clinical spectrum ranges from lethal presentations in infancy to mild, late-onset disease. |
Myringoplasty epitympanic, type I |
Myringoplasty (procedure) |
Myringoplasty using graft (& biological) |
Formal myringoplasty using biological graft |
Myringotomy |
Tympanotomy (procedure) |
Myringotomy |
Myringotomy and drainage of middle ear (procedure) |
Myringotomy and insertion tube: [long term grommet] or [named tube] |
Myringotomy and insertion of long-term ventilation tube |
Myringotomy with aspiration and drainage |
Myringotomy and insertion of tympanic ventilation tube (procedure) |
Myringotomy with aspiration and drainage |
Myringotomy and drainage of middle ear (procedure) |
Myroides species |
Genus Myroides (organism) |
Myxotrichum species |
Myxotrichum (organism) |
NIDDM with peripheral circulatory disorder |
Peripheral circulatory disorder due to type 2 diabetes mellitus (disorder) |
Naevoxanthoendothelioma |
Juvenile xanthogranuloma (disorder) |
Naevoxanthoendothelioma |
Multiple eruptive juvenile xanthogranuloma (disorder) |
Naevoxanthoendothelioma |
Xanthoma disseminatum (disorder) |
Naevus spilus |
Lentiginosis (disorder) |
Nail NEC |
Entire nail unit (body structure) |
Nail bed operation: [excision (& Zadik)] or [ablation] |
Ablation of nail bed |
Nail bed operation: [excision (& Zadik)] or [ablation] |
Zadik procedure |
Nail bed operation: [excision (& Zadik)] or [ablation] |
Total excision of nail plate |
Nail disease NOS |
Disorder of nail (disorder) |
Nail part |
Nail plate part (body structure) |
Nail plate |
Nail plate is the horny translucent plate of nail unit. |
Nail plate |
Entire nail plate (body structure) |
Nail procedure |
Procedure on nail |
Nail procedure |
Nail operations |
Nail removal: [avulsion (& Fowler)] or [NEC] |
Removal of nail plate |
Nail removal: [avulsion (& Fowler)] or [NEC] |
Total avulsion of nail plate |
Nail structure |
Nail unit is a complex structure which consists of nail plate, nail bed, nail root and skin around the nail plate. |
Nail varnish resin |
Nail polish |
Nail(s): [brittle] or [other specified disease NOS] |
Trachyonychia |
Nail: [partial excision NEC] or [refashioning ingrowing toe] |
Refashioning of ingrowing toenail |
Nailfold rheumatoid vasculitis |
Rheumatoid arthritis with systemic vasculitis (disorder) |
Nailfold rheumatoid vasculitis |
Rheumatoid arthritis with isolated nailfold vasculitis (disorder) |
Nairovirus |
Genus Nairovirus (organism) |
Nairovirus |
Nairobi sheep disease virus (organism) |
Nalbuphine hydrochloride 10mg/1mL injection |
Product containing precisely nalbuphine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Nalbuphine hydrochloride 10mg/mL injection solution 1mL ampule |
Product containing precisely nalbuphine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Nalbuphine hydrochloride 10mg/mL injection solution 2mL ampule |
Product containing precisely nalbuphine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Nalidixic acid 300mg/5mL s/f suspension |
Nalidixic acid 60 mg/mL oral suspension |
Nalidixic acid adverse reaction |
Nalidixic acid adverse reaction (disorder) |
Nalidixic acid adverse reaction |
Allergy to nalidixic acid |
Nalidixic acid adverse reaction |
Hypersensitivity to nalidixic acid (finding) |
Nalidixic acid sensitivity |
Hypersensitivity to nalidixic acid (finding) |
Nalidixic acid sensitivity |
Allergy to nalidixic acid |
Naloxone hydrochloride 20mcg/mL injection solution 2mL ampule |
Naloxone hydrochloride 20 microgram/mL solution for injection |
Naloxone hydrochloride 400mcg/mL injection solution 1mL prefilled syringe |
Product containing precisely naloxone hydrochloride 400 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Naloxone hydrochloride 400mcg/mL injection solution 2mL prefilled syringe |
Product containing precisely naloxone hydrochloride 400 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Naltrexone microspheres 380mg powder for conventional release solution for injection vial |
Product containing only naltrexone in parenteral dose form (medicinal product form) |
Naltrexone microspheres 380mg powder for injection solution vial + diluent |
Product containing only naltrexone in parenteral dose form (medicinal product form) |
Nandrolone 50mg/mL injection solution 1mL ampule |
Nandrolone decanoate 50 mg/mL solution for injection |
Nape of neck |
Entire posterior portion of neck (body structure) |
Nape of neck |
Structure of surface region of back of neck (body structure) |
Nape of neck |
Structure of posterior region of neck |
Nape of neck |
Entire surface region of back of neck (body structure) |
Naproxen 375mg m/r tablet |
Product containing precisely naproxen 375 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Narcissus pseudo-narcissus |
Jonquil |
Narcissus pseudo-narcissus |
Daffodil |
Narcotherapy |
Narcoanalysis |
Narcotherapy |
Narcotherapy |
Narcotherapy |
Narcosynthesis |
Narcotic poisoning |
Poisoning caused by opioid receptor agonist |
Narcotic poisoning of undetermined intent |
Poisoning caused by opioid receptor agonist |
Naris, entire, anterior or posterior |
Entire naris (body structure) |
Narrow hyphae |
Narrow hyphae of kingdom Fungi detected |
Narrowing or closure of fetal ductus arteriosus |
Narrowing of fetal arterial duct |
Narrowing or closure of fetal ductus arteriosus |
Closure of fetal arterial duct |
Nasal agent |
Product manufactured as nasal dose form (product) |
Nasal airway obstruction |
Nasal congestion |
Nasal airway obstruction |
Nasal congestion |
Nasal airway obstruction |
Nasal congestion |
Nasal airway obstruction |
Nasal obstruction |
Nasal airway obstruction |
Nasal obstruction |
Nasal airway obstruction |
Nasal obstruction |
Nasal antibiotic |
Product manufactured as nasal dose form (product) |
Nasal antiviral |
Product manufactured as nasal dose form (product) |
Nasal breathing aid, internal, reusable |
Nasal breathing aid |
Nasal breathing aid, internal, single-use |
Nasal breathing aid |